What is spatial resolution testing in nuclear medicine?
Spatial resolution testing in nuclear medicine assesses the ability of a gamma camera or SPECT system to distinguish between two closely spaced sources of radioactivity. It evaluates how accurately small structures can be visualised without blurring.
Spatial resolution testing verifies a gamma camera’s ability to distinguish closely spaced sources, ensuring small lesions remain detectable.
Resolution testing is performed periodically using phantoms or line sources to ensure the system maintains expected performance. Degradation in spatial resolution can reduce lesion detectability and compromise diagnostic accuracy.
Understanding the physics
Spatial resolution in a gamma camera is determined by several physical factors, including collimator design, intrinsic detector resolution, photon energy, and source-to-collimator distance.
Resolution testing typically involves imaging:
A bar phantom, containing sets of parallel bars at decreasing separations
A line source, producing a narrow activity profile
At it’s most basic, if the system can clearly distinguish the smallest bar spacing or produce a narrow line image, spatial resolution is adequate.
There are two types of resolution testing:
Intrinsic resolution is measured without the collimator. It reflects the performance of the scintillation crystal and photomultiplier electronics alone.
System resolution includes the collimator and therefore reflects real clinical performance.
Collimator resolution is often the dominant limiting factor. As the distance between the source and collimator increases, geometric blurring increases, and spatial resolution degrades.
Mechanical damage to the collimator, crystal degradation, or electronic instability may all reduce resolution.
In SPECT systems, spatial resolution is also influenced by reconstruction parameters and centre of rotation accuracy. Poor resolution can result in partial volume effects and loss of small lesion conspicuity.
Resolution is typically quantified as the full width at half maximum (FWHM) of a line spread function.
Where this matters clinically
Reduced spatial resolution can lead to:
Blurring of small lesions
Reduced ability to detect small metastases
Loss of quantitative accuracy
Increased partial volume effect
Routine spatial resolution testing ensures consistent diagnostic performance and early detection of equipment deterioration.